Shares of Rentokil Initial plc (OTCMKTS:RTOKY) have received an average rating of “Buy” from the nine brokerages that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $40.00.
Several research analysts recently weighed in on RTOKY shares. Deutsche Bank reissued a “hold” rating on shares of Rentokil Initial in a research report on Friday, July 24th. Credit Suisse Group raised Rentokil Initial from a “neutral” rating to an “outperform” rating in a research report on Monday, June 22nd. Zacks Investment Research raised Rentokil Initial from a “hold” rating to a “buy” rating and set a $40.00 target price on the stock in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. raised Rentokil Initial from a “neutral” rating to an “overweight” rating in a research report on Friday, June 26th. Finally, Morgan Stanley began coverage on Rentokil Initial in a research note on Monday, May 4th. They set an “overweight” rating for the company.
Shares of OTCMKTS RTOKY opened at $35.67 on Tuesday. Rentokil Initial has a 12 month low of $17.93 and a 12 month high of $37.53. The company has a market cap of $13.19 billion, a price-to-earnings ratio of 38.77 and a beta of 0.88. The company has a quick ratio of 0.89, a current ratio of 1.01 and a debt-to-equity ratio of 1.20. The business has a fifty day simple moving average of $33.33 and a 200-day simple moving average of $30.33.
Rentokil Initial Company Profile
Rentokil Initial plc, through its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services from rodents to flying and crawling insects, as well as to other forms of wildlife management for commercial and residential customers.
Recommended Story: Market Timing – The Benefits and the Danger
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.